Biography
Maureen Rutten-van Mölken is Professor of Economic Evaluation of Innovations for Health at the Erasmus School of Health Policy & Management, Erasmus University Rotterdam. She is also the Scientific Director of the Institute for Medical Technology Assessment (IMTA).
She teaches “Health Technology Assessment” and “Pharmaceutical Pricing and Market Access” in the Master-program Health Economics Policy and Law at Erasmus University Rotterdam.
Her expertise includes economic evaluation studies, either alongside clinical trials or using probabilistic decision-analytic modeling, and outcomes research. She worked in many disease areas, including respiratory diseases (COPD, asthma), rheumatology, diabetes, cardiovascular disease, and Pompe disease. She has a special interest in the cost-effectiveness and the financing and payment of complex multi-faceted interventions that involve system-level changes like integrated care programs, disease management programs, hospital at home programs, outpatient rehabilitation programs, etc. She also has an interest in the health economics of personalized medicine.
She has almost 30 years of experience and has been leading many applied economic evaluations and HTA methods-studies leading to high-level publications. She is the coordinator of SELFIE, a Horizon2020 project on integrated care in multi-morbidity, and contributes to Horizon2020 project HEcoPerMed that develops guidance on health economic modeling, and financing and payment strategies for personalized medicine.
She was trained as a health scientist and had additional training in health economics and epidemiology. She obtained an MSc in Health Care Policy and Management at Maastricht University (1988), and a PhD in Health Economics, also at Maastricht University (1994). She joined iMTA as a Senior Researcher in 1996. Previously, she was an Assistant Professor in Health Economics and Medical Technology Assessment at the Department of Health Economics of the University of Maastricht.
Erasmus School of Health Policy & Management
- m.rutten@eshpm.eur.nl
More information
Work
- Anne Willemsen, Maureen van Molken, Riam al Dulaimi, Hedi Schelleman, Wim G. Goettsch & Lonneke Timmers (2025) - Preparing for the EU HTA Regulation: Insights from the Dutch Perspective - Journal of Market Access and Health Policy, 13 (3) - doi: 10.3390/jmahp13030035
- Hamraz Mokri, Pieter van Baal & Maureen Rutten van Mölken (2025) - Lifetime Healthcare and Long-Term Care Costs of Heart Failure: Estimates Using Administrative Data from Hospitalized Patients in the Netherlands - PharmacoEconomics - doi: 10.1007/s40273-025-01533-9 - [link]
- Apostolos Tsiachristas & Maureen van Molken (2025) - Financial Incentives to Integrate Care in Europe - doi: 10.1007/978-3-031-25376-8_76-1
- Bart Jan Boverhof, Isaac Corro Ramos, Koen A. Vermeer, Victor A. de Vries, Caroline C.W. Klaver, Wishal D. Ramdas, Hans G. Lemij & Maureen Rutten-van Mölken (2025) - The Cost-Effectiveness of an Artificial Intelligence-Based Population-Wide Screening Program for Primary Open-Angle Glaucoma in The Netherlands - Value in Health, 28 (9), 1317-1326 - doi: 10.1016/j.jval.2025.06.006 - [link]
- Sterre Bour, Lucas Goossens, Sarah J.H. Khidir, Pascal de Jong, Annette van Mil, Maureen van Molken & Elise van Mulligen (2025) - The natural course of health-related quality of life in patients with clinically suspect arthralgia: a longitudinal study in progressors and non-progressors to rheumatoid arthritis - Rheumatology International, 45 (5) - doi: 10.1007/s00296-025-05865-9 - [link]
- M. Kamrul Islam, Admassu N. Lamu, Sabine Ruths, Maureen Rutten van Mölken & Jan Erik Askildsen (2025) - Functional limitations and mental well-being among frail older adults: the mediating effect of social relationships - Aging and Mental Health, 29 (9), 1703-1710 - doi: 10.1080/13607863.2025.2484639 - [link]
- Sterre S. Bour, Lucas M.A. Goossens & Maureen P.M.H. Rutten-van Mölken (2025) - Characterizing a heterogeneous chronic patient population for redesigning person-centred bundled payment models using risk-mitigating measures - European Journal of Health Economics - doi: 10.1007/s10198-025-01762-x - [link]
- Elaine Julian, Tom Belleman, Maria João Garcia, Robin Doeswijk, Rosa Giuliani, Bernhard J. Woermann, Daniel Widmer, Patrick Tilleul, Ruben Casado-Arroyo, Valentina Strammiello, Kate Morgan, Marcus Guardian, Michael Ermisch, Renato Bernardini, Fabrizio Gianfrate, Stefano Capri, Carin de Groot, Mira Pavlovic, Jörg Ruof & Maureen van Molken (2025) - Avoiding Error and Finding the Right Balance in European Health Technology Assessments: Insights Generated by the European Access Academy - Journal of Market Access and Health Policy, 5 (1), 1-16 - doi: 10.3390/jmahp13010006 - [link]
- Joanna Lane, Rhiannon T. Edwards, Balázs Babarczy, Holly Whiteley, Vidya Oruganti, Maureen van Molken, Caroline Costongs, Anant R. Jani, Sarah Wordsworth, Alison Maassen, Apostolos Tsiachristas, Jacob Davies, Bengt Stavenow, Jolanda van Vliet, Steve Wright, Lina Papartyte, Jennifer Catherine Camaradou, Rositsa Koleva-Kolarova & (2025) - A protocol for mobilising novel finance models for collaborative health promotion and disease prevention initiatives: taking a smart capacitating investment approach in the Invest4Health project - Frontiers in Public Health, 12 - doi: 10.3389/fpubh.2024.1426863 - [link]
- Elise Van Mulligen, Sterre S. Bour, Lucas M.A. Goossens, Pascal Hendrik Pieter De Jong, Maureen Rutten-Van Mölken & Annette Van Der Helm-Van Mil (2025) - Is a 1-year course of methotrexate in patients with arthralgia at-risk for rheumatoid arthritis cost-effective?: A cost-effectiveness analysis of the randomised, placebo-controlled TREAT EARLIER trial - Annals of the rheumatic diseases, 84 (1), 68-76 - doi: 10.1136/ard-2024-226286 - [link]
Health Technology Assessment
- Year Level
- master, master, master
- Year
- 2025
- Course Code
- GW4546M
Health Technology Assessment (Eu-HEM)
- Level
- master
- Year Level
- master
- Year
- 2025
- Course Code
- GW4585M
Pharmaceutical Pricing and Market Access
- Year Level
- master, master, master, master
- Year
- 2025
- Course Code
- GW4575M
ESHPM HEPL-HE
- Year
- 2025
- Course Code
- GWMTTHEPL
Master Thesis HEPL
- Level
- master
- Year Level
- master
- Year
- 2025
- Course Code
- GW4555M
Master Thesis HE
- Year Level
- master, master
- Year
- 2025
- Course Code
- GW4592M